Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV MelanomaAxel Hauschild, Ulrich Keilholz, René González et al.|Journal of Clinical Oncology|2009Cited by 545
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S. Dellon, Arsalan Shabbir, Marc E. Rothenberg et al.|New England Journal of Medicine|2022Cited by 452
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR. Sharon Chinthrajah, Allen Radin, Sayantani Sindher et al.|Allergy|2024Cited by 33
Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET StudyMarc E. Rothenberg, Arsalan Shabbir, Evan S. Dellon et al.|Journal of Allergy and Clinical Immunology|2022Cited by 12